Sheila Conway to Chondrosarcoma
This is a "connection" page, showing publications Sheila Conway has written about Chondrosarcoma.
Connection Strength
0.572
-
Granger CJ, Hoyt AK, Moran A, Becker B, Sedani A, Saigh S, Conway SA, Brown J, Galoian K. Cancer stem cells as a therapeutic target in 3D tumor models of human chondrosarcoma: An encouraging future for proline rich polypeptide-1. Mol Med Rep. 2020 Nov; 22(5):3747-3758.
Score: 0.185
-
Moran A, Hoyt A, Sedani A, Granger C, Saigh S, Blonska M, Zhao-Ju L, Conway SA, Pretell J, Brown J, Galoian K. Proline-rich polypeptide-1 decreases cancer stem cell population by targeting BAFF chromatin-remodeling complexes in human chondrosarcoma JJ012 cells. Oncol Rep. 2020 Jul; 44(1):393-403.
Score: 0.181
-
Aarons C, Potter BK, Adams SC, Pitcher JD, Temple HT. Extended intralesional treatment versus resection of low-grade chondrosarcomas. Clin Orthop Relat Res. 2009 Aug; 467(8):2105-11.
Score: 0.165
-
O'Neal S, Potter BK, Adams SC, Pitcher JD. Orthopaedic/radiology/pathology conference: a slow-growing anterior tibial mass in a 37-year-old woman. Clin Orthop Relat Res. 2010 Jan; 468(1):302-6.
Score: 0.042